168 related articles for article (PubMed ID: 33626096)
41. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
Liu H; Wang H; Liu X; Yu T
Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
[TBL] [Abstract][Full Text] [Related]
42. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
43. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
44. CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
Gou W; Zhou X; Liu Z; Wang L; Shen J; Xu X; Li Z; Zhai X; Zuo D; Wu Y
Cancer Lett; 2018 May; 422():19-28. PubMed ID: 29477381
[TBL] [Abstract][Full Text] [Related]
45. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
[TBL] [Abstract][Full Text] [Related]
46. TFPI2 suppresses breast cancer progression through inhibiting TWIST-integrin α5 pathway.
Zhao D; Qiao J; He H; Song J; Zhao S; Yu J
Mol Med; 2020 Apr; 26(1):27. PubMed ID: 32248791
[TBL] [Abstract][Full Text] [Related]
47. Synaptotagmin 7 in twist-related protein 1-mediated epithelial - Mesenchymal transition of non-small cell lung cancer.
Liu X; Li C; Yang Y; Liu X; Li R; Zhang M; Yin Y; Qu Y
EBioMedicine; 2019 Aug; 46():42-53. PubMed ID: 31395502
[TBL] [Abstract][Full Text] [Related]
48. The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma.
Wang J; Nikhil K; Viccaro K; Chang L; Jacobsen M; Sandusky G; Shah K
J Cell Sci; 2017 Mar; 130(6):1078-1093. PubMed ID: 28167680
[TBL] [Abstract][Full Text] [Related]
49. Harmine-inspired design and synthesis of benzo[d]imidazo[2,1-b]thiazole derivatives bearing 1,3,4-oxadiazole moiety as potential tumor suppressors.
Zhao T; Yang Y; Yang J; Cui Y; Cao Z; Zuo D; Zhai X
Bioorg Med Chem; 2021 Sep; 46():116367. PubMed ID: 34425477
[TBL] [Abstract][Full Text] [Related]
50. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
51. Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition.
Tabasum S; Singh RP
Chem Biol Interact; 2019 Apr; 303():14-21. PubMed ID: 30802432
[TBL] [Abstract][Full Text] [Related]
52. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
53. The role of TWIST1 in epithelial-mesenchymal transition and cancers.
Zhu QQ; Ma C; Wang Q; Song Y; Lv T
Tumour Biol; 2016 Jan; 37(1):185-97. PubMed ID: 26602382
[TBL] [Abstract][Full Text] [Related]
54. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.
Wei SC; Fattet L; Tsai JH; Guo Y; Pai VH; Majeski HE; Chen AC; Sah RL; Taylor SS; Engler AJ; Yang J
Nat Cell Biol; 2015 May; 17(5):678-88. PubMed ID: 25893917
[TBL] [Abstract][Full Text] [Related]
55. Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex.
Fattet L; Jung HY; Matsumoto MW; Aubol BE; Kumar A; Adams JA; Chen AC; Sah RL; Engler AJ; Pasquale EB; Yang J
Dev Cell; 2020 Aug; 54(3):302-316.e7. PubMed ID: 32574556
[TBL] [Abstract][Full Text] [Related]
56. TWIST1 promotes invasion through mesenchymal change in human glioblastoma.
Mikheeva SA; Mikheev AM; Petit A; Beyer R; Oxford RG; Khorasani L; Maxwell JP; Glackin CA; Wakimoto H; González-Herrero I; Sánchez-García I; Silber JR; Horner PJ; Rostomily RC
Mol Cancer; 2010 Jul; 9():194. PubMed ID: 20646316
[TBL] [Abstract][Full Text] [Related]
57. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
58. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition.
Li S; Zhang J; Yang H; Wu C; Dang X; Liu Y
Sci Rep; 2015 Jul; 5():12410. PubMed ID: 26174737
[TBL] [Abstract][Full Text] [Related]
59. p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT.
Yang-Hartwich Y; Tedja R; Roberts CM; Goodner-Bingham J; Cardenas C; Gurea M; Sumi NJ; Alvero AB; Glackin CA; Mor G
Mol Cancer Res; 2019 Jan; 17(1):153-164. PubMed ID: 30131448
[TBL] [Abstract][Full Text] [Related]
60. Twist1 and Slug mediate H2AX-regulated epithelial-mesenchymal transition in breast cells.
Weyemi U; Redon CE; Sethi TK; Burrell AS; Jailwala P; Kasoji M; Abrams N; Merchant A; Bonner WM
Cell Cycle; 2016 Sep; 15(18):2398-404. PubMed ID: 27315462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
